Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Naltrexone as Adjunct in Alcoholic Cocaine Dependent Patients - 4

This study has been completed.
University of Texas
Information provided by:
National Institute on Drug Abuse (NIDA) Identifier:
First received: September 20, 1999
Last updated: August 11, 2008
Last verified: August 2008
The purpose of this study is to evaluate naltrexone as an adjunct in alcoholic cocaine dependent patients; concurrent relapse prevention theory.

Condition Intervention Phase
Alcohol-Related Disorders
Cocaine-Related Disorders
Drug: Naltrexone
Phase 2

Study Type: Interventional
Study Design: Primary Purpose: Treatment
Official Title: Naltrexone as an Adjunct in Alcoholic Cocaine Dependent Patients

Resource links provided by NLM:

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:
  • Verified abstinence from cocaine [ Time Frame: over the 12 weeks of study ] [ Designated as safety issue: No ]

Estimated Enrollment: 0
Study Start Date: April 2003
Study Completion Date: April 2007
Primary Completion Date: April 2007 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Please contact site for information.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00000307

United States, Texas
University of Texas Health Science Center
Houston, Texas, United States, 77225
Sponsors and Collaborators
National Institute on Drug Abuse (NIDA)
University of Texas
Principal Investigator: John Grabowski, Ph.D. University of Texas
  More Information

Responsible Party: Joy Schmitz, Ph.D., University of Texas Medical School at Houston Identifier: NCT00000307     History of Changes
Other Study ID Numbers: NIDA-09262-4  P50-09262-4 
Study First Received: September 20, 1999
Last Updated: August 11, 2008
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Cocaine-Related Disorders
Alcohol-Related Disorders
Pathologic Processes
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders
Anesthetics, Local
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents
Vasoconstrictor Agents
Dopamine Uptake Inhibitors
Neurotransmitter Uptake Inhibitors
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Dopamine Agents
Neurotransmitter Agents
Narcotic Antagonists processed this record on October 21, 2016